semaglutide patient information weight loss GLP-1 vs Tirzepatide for in Adults Semaglutide GLP-1 for Weight Loss

One in three Canadians are currently living with obesity, and in 10 years, that number is going to change to about 50 per cent, so this is really an opportunity for policymakers to take action. LISTEN | WHO conditionally recommends GLP-1 drugs for obesity: The WHOs first conditional recommendation advises the use of GLP-1 drugs by adults, except pregnant women, for long-term obesity treatment, while the second suggests interventions like a healthy diet and physical activity to be offered alongside the medicines

ECT remains a proven option

The solution should be kept under the tongue for 5 minutes before swallowing

doi:10.1038/jid.2014.222

I am back